In Treatment of Bacterial infections Zefclav 250 mg/62.5 mg Tablet is used to treat certain bacterial infections such as bronchitis, pneumonia, and infections of the throat, skin, and urinary tract. It works by killing the infection-causing microorganisms. This further reduces the discomforts associated with various infections and helps in early recovery. Make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Consuming alcohol with Zefclav 250 mg/62.5 mg Tablet does not cause any harmful side effects.
Zefclav 250 mg/62.5 mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Zefclav 250 mg/62.5 mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Zefclav 250 mg/62.5 mg Tablet may cause side effects which could affect your ability to drive. Zefclav 250 mg/62.5 mg Tablet may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
Zefclav 250 mg/62.5 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zefclav 250 mg/62.5 mg Tablet may be needed. Please consult your doctor.
Zefclav 250 mg/62.5 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Zefclav 250 mg/62.5 mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Zefclav 250 mg/62.5 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Indoco Remedies Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: FDC Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aristo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)